Skip to main content

Table 3 ME/CFS symptom characteristics

From: Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis/chronic fatigue syndrome patients

Age of diagnosis (Years [Mean ± SD])

 

26.70 ± 12.75

Disease duration (Years [Mean ± SD])

 

17.70 ± 14.95

Infectious onset, n (%)

 

8 (80.0%)

Cognitive difficulties

Yes

10 (100%)

No

0 (0.0%)

Pain

Yes

10 (100%)

No

0 (0%)

Sleep disturbances

Yes

10 (100%)

No

0 (0%)

Sensory disturbances

Yes

9 (90.0%)

No

1 (10.0%)

Immune disturbances

Yes

9 (90.0%)

No

1 (10.0%)

Gastrointestinal disturbances

Yes

9 (90.0%)

No

1 (10.0%)

Cardiovascular disturbances

Yes

8 (80.0%)

No

2 (20.0%)

Respiratory disturbances

Yes

8 (90.0%)

No

2 (20.0%)

Thermostatic instability

Yes

10 (100%)

No

0 (0%)

Urinary disturbances

Yes

5 (50.0%)

No

5 (50.0%)

  1. ME Myalgic encephalomyelitis, CFS chronic fatigue syndrome, SD standard deviation, n number